Newron opens Swiss R&D center in Basel

Italy-based Newron Pharmaceuticals SpA plans to open a clinical development facility in Basel, Switzerland, this month. The new operations will be incorporated into a fully-owned subsidiary, called Newron Suisse SA, and will complement the firm's headquarters in Bresso, Milan.

According to Newron, the Basel region is one of Europe's key pharmaceutical/biotechnology clusters in which it will be well-positioned to attract talented research and development professionals to further strengthen its international clinical development activities and to broaden its strong pipeline of compounds, targeting novel therapies for diseases of the central nervous system and pain. Initially Newron Suisse will be staffed with five senior professionals, as part of a gradual expansion. Newron was aided in the process of finding a site by Basel Area Business Development.

...and reports first-half 2007 loss of 3.9 million euros